Evidence map›Paper›PMID 38171044›Full record

ReviewCurrent opinion in genetics & development2024

Deciphering microglia phenotypes in health and disease.

Christopher D Balak, Claudia Z Han, Christopher K Glass

Abstract readReview
In one paragraph

Review in Current opinion in genetics & development, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christopher D BalakDepartment of Cellular and Molecular Medicine, University of California, San Diego, USA; Biomedical Sciences Graduate Program, University of California, San Diego, USA.
Claudia Z HanDepartment of Cellular and Molecular Medicine, University of California, San Diego, USA.
Christopher K GlassDepartment of Cellular and Molecular Medicine, University of California, San Diego, USA; Department of Medicine, University of California, San Diego, USA. Electronic address: ckg@ucsd.edu.

Funding

Training Program in Basic Clinical GeneticsT32GM008666 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HAMILTON, BRUCE A · 1998 to 2021
$8.6M
Mechanisms controlling human microglia gene expressionR01NS096170 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLASS, CHRISTOPHER K · 2016 to 2025
$4.3M
Gene regulatory networks influencing neuron-microglia interactions in fetal brain development.K99MH129983 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HAN, CLAUDIA Z · 2022 to 2023
$230k
NIGMS NIH HHS T32 GM008666NIMH NIH HHS K99 MH129983NINDS NIH HHS R01 NS096170
6 · The paper itself

Abstract

Microglia are the major immune cells of the central nervous system (CNS) that perform numerous adaptive functions required for normal CNS development and homeostasis but are also linked to neurodegenerative and behavioral diseases. Microglia development and function are strongly influenced by brain environmental signals that are integrated at the level of transcriptional enhancers to drive specific programs of gene expression. Here, we describe a conceptual framework for how lineage-determining and signal-dependent transcription factors interact to select and regulate the ensembles of enhancers that determine microglia development and function. We then highlight recent findings that advance these concepts and conclude with a consideration of open questions that represent some of the major hurdles to be addressed in the future.

Indexed as

MicrogliaNeurodegenerative DiseasesBrainCentral Nervous SystemHumansPhenotype

Identifiers

PMID38171044
PMCPMC12118495

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.